Medplus Health Services Announces 20th AGM on Aug 17, 2026, to Appoint New Directors and MD & CEO
Medplus Health Services will hold its 20th AGM on August 17, 2026. Key agendas include approving FY26 financial statements and appointing Mr. Mohan Krishna Reddy and Mr. Ajit Pandurang Rangnekar as Independent Directors. Mr. Gangadi Madhukar Reddy is proposed for re-appointment as MD & CEO for five years.
The appointment of new directors and the re-appointment of the MD & CEO are material events that can influence the company's strategic direction and governance. These changes are significant for stakeholders.
The announcement is a routine notice for an Annual General Meeting, detailing agenda items and appointments. While these appointments are significant for the company's governance, they do not inherently indicate a positive or negative shift in performance or outlook.
Medplus Health Services Limited has announced its 20th Annual General Meeting (AGM) for the Financial Year 2025-26, scheduled to be held on Monday, August 17, 2026, at 03:30 PM (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
The AGM will focus on several key business agendas including the adoption of Audited Standalone & Consolidated Financial Statements for the Financial Year ended March 31, 2026, and the Reports of the Board of Directors and Auditors thereon.
Furthermore, the meeting will seek shareholder approval for significant appointments. Mr. Mohan Krishna Reddy and Mr. Ajit Pandurang Rangnekar are proposed to be appointed as Independent Directors. Additionally, Mr. Gangadi Madhukar Reddy is proposed for re-appointment as the Managing Director & CEO for a term from August 03, 2026, to August 02, 2031, with a consolidated remuneration not exceeding ₹4.00 million per annum. The appointment of Cost Auditors for the Financial Year 2026-27 and the ratification of their remuneration will also be on the agenda.
The company will also address the retirement of Dr. Cherukupalli Bhaskar Reddy, Whole Time Director, by rotation.
What to do with a filing like this
Medplus Health Services Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Medplus Health Services Limited. Read the original for the full detail.